Rate My Professor Marion Bennie

Bennie's research specializations lie in pharmacoepidemiology, pharmacy practice, and healthcare interventions, with a focus on developing robust evidence bases from real-world data to support safe, effective, and person-centred care via medicines and health technologies. She has led significant initiatives, including research on the safer use of high-risk medicines, which has influenced Scottish healthcare policy since 2010, prompted service redesigns in all Scottish pharmacies, and contributed to measurable outcomes such as a 30% reduction in elderly patients exposed to high-risk medicine combinations and a 16% decrease in NSAID prescribing volume in general practices from 2018 to 2020. Her work has also informed the Scottish Patient Safety Programme – Pharmacy in Primary Care and international adaptations, such as in New Zealand. Bennie has earned prestigious honors, including Fellow of the Faculty of Public Health, Fellow of the Royal Pharmaceutical Society, and Fellow of the Royal Society of Physicians of Edinburgh, all awarded in 2024, alongside research poster prizes such as Best Researcher in 2024 and second place in Health Services Research Pharmacy Practice in 2022. Key publications include 'UK Antimicrobial Registry: Virtual - An innovative surveillance approach for monitoring the real-world use and effectiveness of newly licensed antimicrobials in Scotland' (2026, JAC-Antimicrobial Resistance), 'A roadmap to embedding real-world evidence into Health Technology Assessment processes for cancer medicines: experiences from Scotland' (2026, Value in Health), 'Public Health Scotland (PHS) homecare medicines dataset' (2026, International Journal of Population Data Science), and 'Data Resource Profile: The Scottish Combined Medicines Dataset (SCoMeD)' (2026, International Journal of Population Data Science). She contributes to committees like the Scottish Cancer PROMs Advisory Group.